Found: 4
Select item for more details and to access through your institution.
Dapagliflozin does not influence arterial stiffness or other bio-markers of arterial ageing in people with type 2 diabetes and kidney disease.
- Published in:
- Artery Research, 2023, v. 29, n. 1, p. S27, doi. 10.1007/s44200-022-00028-8
- By:
- Publication type:
- Article
P.64 Active Vitamin D Treatment Does Not Improve Arterial Stiffness and Markers of Cardio-Renal Risk in Patients with Type 2 Diabetes and Stage 3 Chronic Kidney Disease: a Randomised Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
IgA nephropathy in Greece: data from the registry of the Hellenic Society of Nephrology.
- Published in:
- Clinical Kidney Journal, 2018, v. 11, n. 1, p. 38, doi. 10.1093/ckj/sfx076
- By:
- Publication type:
- Article
Effect of calcitriol treatment on arterial stiffness in people with type 2 diabetes and stage 3 chronic kidney disease.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 1, p. 279, doi. 10.1111/bcp.15484
- By:
- Publication type:
- Article